SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-000630
Filing Date
2019-08-01
Accepted
2019-08-01 16:22:57
Documents
13
Period of Report
2019-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv526520_8k.htm   iXBRL 8-K 29837
2 EXHIBIT 10.1 tv526520_ex10-1.htm EX-10.1 582598
  Complete submission text file 0001410578-19-000630.txt   873839

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA irwd-20190801.xsd EX-101.SCH 3205
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20190801_lab.xml EX-101.LAB 33476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20190801_pre.xml EX-101.PRE 21971
6 EXTRACTED XBRL INSTANCE DOCUMENT tv526520_8k_htm.xml XML 3497
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 19993013
SIC: 2834 Pharmaceutical Preparations